Kelley Shannon T sold $342K of MDGL
Kelley Shannon T (General Counsel) sold 664 shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at $514.97 ($0.34M total) on 2026-08-17.
How this was made
The 30-second read
Why it matters
The sale reduces insider ownership modestly; market may view as neutral to slightly negative.
Market read
Small insider sale with limited price impact; traders may monitor for further insider activity.
What to watch
Potential upcoming clinical data or regulatory events not disclosed.
Background
Form 4 filing reports insider transactions for publicly traded companies.
Ticker impact
General Counsel Kelley Shannon T sold 664 shares for $341,940, reducing her stake to 11,474 shares.
Potential slight downward pressure in short term.
Form 4 filing is primary source; sale size under $1M limits material impact.
Market effects
Minimal effect on biotech sector; typical insider sell.
No regional impact.
Low global relevance.
Counterpoint
Insider may be diversifying; sale does not reflect company fundamentals.
Key entities
- CompanyMadrigal Pharmaceuticals, Inc.
Biotech firm developing therapies for liver disease.
- PersonKelley Shannon T
General Counsel of Madrigal Pharmaceuticals.